What is PSC Biotech?
Founded in 1996, PSC Biotech operates as a critical service provider for the life sciences industry, specializing in the development, manufacturing, and distribution of healthcare products. The company serves as a vital bridge between innovation and market readiness, ensuring that all processes adhere to the highest global regulatory standards. Its market position is defined by over two decades of operational excellence, providing essential compliance consulting and technical services that mitigate risk for pharmaceutical and biotechnology firms. By embedding itself into the core workflows of its clients, PSC Biotech has become an indispensable partner for organizations navigating the increasingly complex landscape of global health regulations.
How much funding has PSC Biotech raised?
PSC Biotech has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in PSC Biotech
PPP
Public-Private Partnership
What's next for PSC Biotech?
With the infusion of this major enterprise-level funding, PSC Biotech is well-positioned to scale its service offerings and deepen its technological integration within the life sciences ecosystem. The strategic allocation of this capital will likely focus on expanding its footprint in emerging markets and enhancing its digital compliance platforms to meet the evolving needs of modern drug development. As the industry faces heightened scrutiny and a push for faster time-to-market, PSC Biotech's ability to provide scalable, compliant solutions will be a primary driver of its future growth. The company is expected to leverage this financial momentum to solidify its leadership in regulatory advisory and technical support, ensuring that it remains at the forefront of the global healthcare manufacturing sector.
See full PSC Biotech company page
